ACVDP-DMG

Drug Profile

ACVDP-DMG

Alternative Names: Aciclovir diphosphate dimyristoylglycerol; Aciclovir diphosphate-DMG; VN 1703

Latest Information Update: 30 Jun 1999

Price : $50

At a glance

  • Originator Vical
  • Developer Gilead Sciences; Vical
  • Class Antivirals; Nucleosides
  • Mechanism of Action DNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Herpes simplex virus infections

Most Recent Events

  • 30 Jun 1999 Discontinued-Preclinical for Herpes simplex virus infections in USA (Unknown route)
  • 06 Aug 1998 No-Development-Reported for Herpes simplex virus infections in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top